These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26767875)

  • 1. First Korean case of Emberger syndrome (primary lymphedema with myelodysplasia) with a novel GATA2 gene mutation.
    Seo SK; Kim KY; Han SA; Yoon JS; Shin SY; Sohn SK; Moon JH
    Korean J Intern Med; 2016 Jan; 31(1):188-90. PubMed ID: 26767875
    [No Abstract]   [Full Text] [Related]  

  • 2. Emberger syndrome: A rare association with hearing loss.
    Zawawi F; Sokolov M; Mawby T; Gordon KA; Papsin BC; Cushing SL
    Int J Pediatr Otorhinolaryngol; 2018 May; 108():82-84. PubMed ID: 29605372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rare Case of Emberger Syndrome Caused By a De Novo Mutation in the GATA2 Gene.
    Michelini S; Cardone M; Haag M; Agga O; Bruson A; Maltese PE; Bonizzato A; Bertelli M
    Lymphology; 2016 Mar; 49(1):15-20. PubMed ID: 29906059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia.
    Ishida H; Imai K; Honma K; Tamura S; Imamura T; Ito M; Nonoyama S
    Eur J Pediatr; 2012 Aug; 171(8):1273-6. PubMed ID: 22430350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
    Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
    Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulomatous lung disease in a patient with a family history of hematological disorders.
    Overbeek MJ; van de Loosdrecht AA; Vonk-Noordegraaf A
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):350-3. PubMed ID: 25591147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
    Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
    Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).
    Ostergaard P; Simpson MA; Connell FC; Steward CG; Brice G; Woollard WJ; Dafou D; Kilo T; Smithson S; Lunt P; Murday VA; Hodgson S; Keenan R; Pilz DT; Martinez-Corral I; Makinen T; Mortimer PS; Jeffery S; Trembath RC; Mansour S
    Nat Genet; 2011 Sep; 43(10):929-31. PubMed ID: 21892158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome.
    Brambila-Tapia AJL; García-Ortiz JE; Brouillard P; Nguyen HL; Vikkula M; Ríos-González BE; Sandoval-Muñiz RJ; Sandoval-Talamantes AK; Bobadilla-Morales L; Corona-Rivera JR; Arnaud-Lopez L
    Hematology; 2017 Sep; 22(8):467-471. PubMed ID: 28271814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA2 mutations lead to MDS and AML.
    Hyde RK; Liu PP
    Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
    [No Abstract]   [Full Text] [Related]  

  • 11. GATA2 Deficiency in a Pediatric Patient.
    Mojica AM; Elizalde A
    J Allergy Clin Immunol Pract; 2019; 7(6):2021-2022. PubMed ID: 30894283
    [No Abstract]   [Full Text] [Related]  

  • 12. GATA2 deficiency in a young man with lymphoedema.
    Mishra SS; Williams JF; G Paterson B; George A
    Br J Haematol; 2020 Oct; 191(2):142. PubMed ID: 32643807
    [No Abstract]   [Full Text] [Related]  

  • 13. GATA2 is required for lymphatic vessel valve development and maintenance.
    Kazenwadel J; Betterman KL; Chong CE; Stokes PH; Lee YK; Secker GA; Agalarov Y; Demir CS; Lawrence DM; Sutton DL; Tabruyn SP; Miura N; Salminen M; Petrova TV; Matthews JM; Hahn CN; Scott HS; Harvey NL
    J Clin Invest; 2015 Aug; 125(8):2979-94. PubMed ID: 26214525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facial lymphoedema, viral warts, and myelodysplastic syndrome: the protean condition of GATA2 deficiency.
    Rudd EC; Kulasekararaj A; Basu TN
    Lancet; 2022 Jul; 400(10347):236. PubMed ID: 35843247
    [No Abstract]   [Full Text] [Related]  

  • 15. The evolution of cellular deficiency in GATA2 mutation.
    Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
    Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia.
    Holme H; Hossain U; Kirwan M; Walne A; Vulliamy T; Dokal I
    Br J Haematol; 2012 Jul; 158(2):242-248. PubMed ID: 22533337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA2 Deficiency Due to de Novo Complete Monoallelic Deletion in an Adolescent With Myelodysplasia.
    Vinh DC; Palma L; Storring J; Foulkes WD
    J Pediatr Hematol Oncol; 2018 May; 40(4):e225-e228. PubMed ID: 29620682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
    Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
    Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies.
    Wang X; Muramatsu H; Okuno Y; Sakaguchi H; Yoshida K; Kawashima N; Xu Y; Shiraishi Y; Chiba K; Tanaka H; Saito S; Nakazawa Y; Masunari T; Hirose T; Elmahdi S; Narita A; Doisaki S; Ismael O; Makishima H; Hama A; Miyano S; Takahashi Y; Ogawa S; Kojima S
    Haematologica; 2015 Oct; 100(10):e398-401. PubMed ID: 26022708
    [No Abstract]   [Full Text] [Related]  

  • 20. Skin manifestations among GATA2-deficient patients.
    Polat A; Dinulescu M; Fraitag S; Nimubona S; Toutain F; Jouneau S; Poullot E; Droitcourt C; Dupuy A
    Br J Dermatol; 2018 Mar; 178(3):781-785. PubMed ID: 28440875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.